Publications by authors named "Ruth Morrell"

Claim this Profile
R
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.
Eimear O' Reilly, Sukhraj Pal S Dhami, Denis V Baev, Csaba Ortutay, Anna Halpin-McCormick, Ruth Morrell

Sci Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.
Sarah L McCarron, Stephen E Langabeer, Karen Bolger, Karl Haslam, Mireille Crampe, Ruth Morrell

Med Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia.
Ruth Morrell, Stephen E Langabeer, Liam Smyth, Meegahage Perera, Gerard Crotty

Case Rep Hematol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis.
Marianne van Dijk, Eoin Murphy, Ruth Morrell, Steven Knapper, Michael O'Dwyer

Cancers (Basel)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis